Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Krystal Biotech, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Krystal Biotech, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Krystal Biotech, Inc. since 2005.
The reporting company's ticker symbol is KRYS. The reporting company's CIK number is 1711279.
The total value of stock buying since 2005 is $4,957,387.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-06-06||Krishnan Suma (Chief Operating Officer)||Buy||14,134||11.80||166,752|
|2018-06-05||Krishnan Suma (Chief Operating Officer)||Buy||10,866||10.74||116,755|
|2018-05-22||Riley Antony A (Chief Financial Officer)||Buy||2,800||10.75||30,100|
|2018-05-09||Norby R Douglas (Director)||Buy||9,000||10.42||93,780|
|2018-03-19||Krishnan Krish S (President and CEO)||Buy||50,000||11.00||550,000|
|2017-09-22||Krishnan Suma (Chief Operating Officer)||Buy||100,000||10.00||1,000,000|
|2017-09-22||Krishnan Krish S (President and CEO)||Buy||100,000||10.00||1,000,000|
|2017-09-22||Janney Daniel (Director)||Buy||200,000||10.00||2,000,000|
Insider trading activities including stock purchases, stock sales, and option exercises of KRYS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Krystal Biotech, Inc. (symbol KRYS, CIK number 1711279) see the Securities and Exchange Commission (SEC) website.